您的位置: 首页 > 农业专利 > 详情页

ANTICORPS MONOCLONAUX HUMAINS DIRIGES CONTRE UN LIGAND DE MORT PROGRAMMEE DE TYPE 1(PD-L1)
专利权人:
INC.;MEDAREX
发明人:
KORMAN, ALAN J.,SELBY, MARK J.,WANG, CHANGYU,SRINIVASAN, MOHAN,PASSMORE, DAVID B.,HUANG, HAICHUN,CHEN, HAIBIN
申请号:
CA2612241
公开号:
CA2612241C
申请日:
2006.06.30
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present disclosure provides isolated monoclonal antibodies, particularlyhuman monoclonal antibodies that specifically bind to PD-Ll with highaffinity. Nucleic acid molecules encoding the antibodies of this disclosure,expression vectors, host cells and methods for expressing the antibodies ofthis disclosure are also provided. Immunoconjugates, bispecific molecules andpharmaceutical compositions comprising the antibodies of the invention arealso provided. The disclosure also provides methods for detecting PD-Ll, aswell as methods for treating various diseases, including cancer and infectiousdiseases, using anti-PD-Ll antibodies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充